Free shipping on all orders over $ 500

Vapreotide acetate

Cat. No. M10332
Vapreotide acetate Structure
Synonym:

BMY-41606; RC160; Octastatin acetate

Size Price Availability Quantity
5mg USD 90  USD100 In stock
10mg USD 135  USD150 In stock
25mg USD 225  USD250 In stock
50mg USD 405  USD450 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

Vapreotide acetate (BMY-41606 acetate; RC160 acetate) is a neurokinin-1 (NK1) receptor antagonist with IC50 value of 330 nM. Vapreotide inhibits SP-induced IL-8 and MCP-1 production in HEK293-NK1R and U373MG cell lines. Vapreotide also inhibits HIV-1 infection of human MDM in vitro, an effect that is reversible by SP pretreatment. Vapreotide inhibits serum-induced proliferation of CHO cells expressing SSTR2 and SSTR5 with EC50 of 53 and 150 pM, respectively.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 1191.39
Formula C59H74N12O11S2
CAS Number 849479-74-9
Purity >99%
Solubility Water 11 mg/mL
Storage -20°C, sealed
References

Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor
Sergei Spitsin, et al. Neuroimmunomodulation. 2013;20(5):247-55. PMID: 23921645.

Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis
Nary Veal, et al. Dig Dis Sci. 2003 Jan;48(1):154-61. PMID: 12645803.

Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells
L J Hofland, et al. Endocrinology. 1994 Jan;134(1):301-6. PMID: 7903931.

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
L Buscail, et al. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1580-4. PMID: 7878022.

Related Neurokinin Receptor Products
[Leu31,Pro34]-NPY TFA (human,rat)

[Leu31,Pro34]-NPY TFA (human,rat) is a specific neuropeptide Y1 receptor agonist.

Ibodutant

Ibodutant (MEN15596) is a potent and selective tachykinin NK2 receptor antagonist with a pKi of 10.1.

Serlopitant

Serlopitant is a selective Neurokinin-1 (NK-1) receptor antagonist.

Substance P

Substance P is a neuropeptide, acting as a neurotransmitter and as a neuromodulator.The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R).

SCH 619734

SCH-619734 is an orally bioavailable, centrally-acting, selective neurokinin 1 receptor (NK1-receptor) antagonist with a Ki of 0.66 nM.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: Vapreotide acetate, BMY-41606; RC160; Octastatin acetate supplier, Neurokinin Receptor, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.